ALBO insider transactions
Albireo Pharma Inc. (ALBO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for ALBO
- SEC Form 4: Chiswell David closing all direct ownership in the company4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4 filed by Alesina Susan4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4 filed by Okey Stephanie4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Harford Simon N.R. closing all direct ownership in the company4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Cooper Ronald Harold Wilfred closing all direct ownership in the company4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4 filed by Streck Paul4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Stephenson Pamela closing all direct ownership in the company4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Graham Michelle closing all direct ownership in the company4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4 filed by Gutch Michael4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Carter Martha J. decreased direct ownership by 50% to 3,654 units4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Duncan Jason closing all direct ownership in the company4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Mattsson Jan closing all direct ownership in the company4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4 filed by Dable Habib J4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4 filed by Scoon Davey4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4 filed by Hopkinson Craig C.4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Mattsson Jan was granted 55,000 shares, increasing direct ownership by 101% to 109,474 units (Amendment)4/A - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Cooper Ronald Harold Wilfred was granted 195,000 shares, increasing direct ownership by 339% to 252,444 units (Amendment)4/A - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Carter Martha J. was granted 55,000 shares, increasing direct ownership by 379% to 69,506 units (Amendment)4/A - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Duncan Jason was granted 55,000 shares, increasing direct ownership by 389% to 69,146 units (Amendment)4/A - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Graham Michelle was granted 32,000 shares, increasing direct ownership by 131% to 56,493 units (Amendment)4/A - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Harford Simon N.R. was granted 55,000 shares, increasing direct ownership by 168% to 87,689 units (Amendment)4/A - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Stephenson Pamela was granted 55,000 shares, increasing direct ownership by 129% to 97,755 units (Amendment)4/A - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Streck Paul was granted 55,000 shares, increasing direct ownership by 86% to 118,966 units (Amendment)4/A - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Cooper Ronald Harold Wilfred was granted 195,000 shares, increasing direct ownership by 339% to 252,444 units4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Mattsson Jan was granted 55,000 shares, increasing direct ownership by 101% to 109,474 units4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Carter Martha J. was granted 55,000 shares, increasing direct ownership by 379% to 69,506 units4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Duncan Jason was granted 55,000 shares, increasing direct ownership by 389% to 69,146 units4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Graham Michelle was granted 32,000 shares, increasing direct ownership by 131% to 56,493 units4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Harford Simon N.R. was granted 55,000 shares, increasing direct ownership by 168% to 87,689 units4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Stephenson Pamela was granted 55,000 shares, increasing direct ownership by 129% to 97,755 units4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Streck Paul was granted 55,000 shares, increasing direct ownership by 86% to 118,966 units4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Stephenson Pamela sold $4,468 worth of shares (102 units at $43.80) as part of a pre-agreed trading plan, decreasing direct ownership by 0.24% to 42,755 units to cover withholding tax4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Graham Michelle sold $4,468 worth of shares (102 units at $43.80) as part of a pre-agreed trading plan, decreasing direct ownership by 0.41% to 24,493 units to cover withholding tax4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Mattsson Jan sold $8,629 worth of shares (197 units at $43.80) as part of a pre-agreed trading plan, decreasing direct ownership by 0.36% to 54,474 units (tax liability)4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Cooper Ronald Harold Wilfred sold $46,297 worth of shares (1,057 units at $43.80) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 57,444 units (withholding tax)4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Duncan Jason sold $9,986 worth of shares (228 units at $43.80) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 14,146 units (for tax liability)4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Harford Simon N.R. sold $4,468 worth of shares (102 units at $43.80) as part of a pre-agreed trading plan, decreasing direct ownership by 0.31% to 32,689 units (withholding obligation)4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Carter Martha J. sold $5,256 worth of shares (120 units at $43.80) as part of a pre-agreed trading plan, decreasing direct ownership by 0.82% to 14,506 units (withholding tax)4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Carter Martha J. sold $41,182 worth of shares (938 units at $43.90) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 14,626 units to satisfy withholding tax4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Stephenson Pamela sold $77,886 worth of shares (1,774 units at $43.90) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 42,857 units (withholding obligation)4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Duncan Jason sold $41,182 worth of shares (938 units at $43.90) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 14,374 units (withholding tax)4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Harford Simon N.R. sold $77,789 worth of shares (1,776 units at $43.80) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 32,791 units to cover taxes4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Mattsson Jan sold $135,254 worth of shares (3,088 units at $43.80) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 54,671 units (withholding tax)4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Graham Michelle sold $77,886 worth of shares (1,774 units at $43.90) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 24,595 units to satisfy withholding obligation4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Stephenson Pamela sold $8,940 worth of shares (469 units at $19.06) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 44,631 units to satisfy withholding tax (Amendment)4/A - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Stephenson Pamela sold $2,615 worth of shares (106 units at $24.67) as part of a pre-agreed trading plan, decreasing direct ownership by 0.23% to 45,649 units (for tax liability) (Amendment)4/A - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Cooper Ronald Harold Wilfred sold $17,991 worth of shares (919 units at $19.58) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 58,501 units (tax liability) (Amendment)4/A - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Stephenson Pamela sold $8,940 worth of shares (469 units at $19.06) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 45,178 units (withholding obligation)4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Streck Paul was granted 63,966 shares4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 3 filed by new insider Streck Paul3 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 3 filed by new insider Hopkinson Craig C.3 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Hopkinson Craig C. was granted 10,495 shares4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Duncan Jason sold $12,756 worth of shares (656 units at $19.45) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 14,931 units (tax liability)4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Stephenson Pamela sold $2,036 worth of shares (104 units at $19.58) as part of a pre-agreed trading plan, decreasing direct ownership by 0.23% to 45,647 units (for tax liability)4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Mattsson Jan sold $3,954 worth of shares (202 units at $19.58) as part of a pre-agreed trading plan, decreasing direct ownership by 0.35% to 57,759 units (tax withholding)4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Harford Simon N.R. sold $2,036 worth of shares (104 units at $19.58) as part of a pre-agreed trading plan, decreasing direct ownership by 0.31% to 33,295 units to satisfy withholding tax4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Cooper Ronald Harold Wilfred sold $17,991 worth of shares (919 units at $19.58) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 55,461 units to satisfy withholding tax4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Carter Martha J. sold $2,036 worth of shares (104 units at $19.58) as part of a pre-agreed trading plan, decreasing direct ownership by 0.66% to 15,564 units (for withholding tax)4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Graham Michelle sold $2,036 worth of shares (104 units at $19.58) as part of a pre-agreed trading plan, decreasing direct ownership by 0.39% to 26,369 units (withholding obligation)4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)
- SEC Form 4: Perceptive Advisors Llc sold $9,505,547 worth of shares (420,416 units at $22.61)4 - ALBIREO PHARMA, INC. (0001322505) (Issuer)